News

According to the complaint, Phreesia sold investors on a growth story. Its healthcare platform was expanding. AI tools w... Learn More

Graphic Packaging told investors it had a strong and steady business. Stable margins. Healthy inventory. Big cash flow a... Learn More

FS KKR Capital told investors its credit portfolio was getting stronger. According to the complaint, non-accrual problem... Learn More

POET Technologies told investors it was positioned for the AI chip race. Big customers. Major purchase orders. Strong gr... Learn More

According to the complaint, SES AI told investors it was building the future of batteries with AI. Big partnerships. Mas... Learn More

Regencell told investors it was developing traditional Chinese medicine treatments for ADHD and autism. A tiny company w... Learn More

Globant told investors Latin America was its next big success story. A $1 billion expansion. Strong demand. Rapid growth... Learn More

LKQ told investors its $2.1 billion Uni-Select deal, including FinishMaster, would drive growth and strengthen its marke... Learn More

Babcock & Wilcox told investors it had landed a transformational AI data center power deal worth over $1.5 billion. ... Learn More

United Homes told investors it was exploring “strategic alternatives” to maximize shareholder value. It sounded disc... Learn More

Medpace told investors cancellations were “well behaved” and a 1.15 book to bill was still in reach. Growth looked s... Learn More

Stellantis told investors 2025 would be the year growth came back. Electrification was “growing,” margins were suppo... Learn More

Upstart told investors its AI was getting smarter. Model 22 was supposed to approve more borrowers, lift conversion rate... Learn More

ImmunityBio told investors it was sitting on a breakthrough. A cancer treatment with massive potential. Even framed as a... Learn More

Super Micro told investors it was riding the AI wave. Record demand. Explosive growth. Billions in revenue. But behind t... Learn More

Atara told investors it was on the verge of a breakthrough. A first of its kind cancer therapy. Strong data. FDA approva... Learn More

Coty told investors a comeback was already underway. Growth was coming back. Profits were set to rebound. Everything lo... Learn More

Lufax told investors its financials were strong. Controls were effective. Profits were accurate. But behind the scenes, ... Learn More

Hercules Capital told investors it had a disciplined system. Rigorous due diligence. Careful valuations. A growing port... Learn More

Power Solutions told investors it was tapping into booming data center demand. High growth. Higher margins. A booming fu... Learn More

Concorde told investors it offered technology-driven security services with recurring revenue. But according to a recent... Learn More

Alight told investors a new era had arrived. A seasoned CEO. Strong growth. Reliable dividends. A steady path forward. B... Learn More

Gartner told investors growth was accelerating. Projected accelerating contract value growth. Pointing to a path toward ... Learn More

Oddity Tech told investors its AI-driven beauty platform was delivering strong growth and profitability. But behind the ... Learn More

Trip.com told investors it was the go to platform for global travel. A powerful one stop shop connecting millions of tra... Learn More

Camping World told investors its data-driven inventory strategy was strengthening margins and positioning the company fo... Learn More

monday.com told investors the future looked huge. AI innovation. Enterprise expansion. A bold goal of $1.8 billion in re... Learn More

Driven Brands told investors its financial reporting was solid. The numbers looked clean. The business looked stable. Bu... Learn More

Soleno promised a breakthrough. A first of its kind treatment for a rare disorder. Executives said their drug VYKAT XR w... Learn More

Boston Scientific told investors its heart rhythm business was growing fast. Growth looked strong and sustainable. The c... Learn More

Aquestive Therapeutics told investors it had developed a breakthrough treatment. A tiny film for severe allergic reactio... Learn More

For years, Apollo Global told investors the same thing. The firm said it had never done business with Jeffrey Epstein. B... Learn More

Franklin BSP Realty Trust told investors the dividend was solid. $0.355 cents a quarter. Presented as sustainable. Suppo... Learn More

Snowflake Inc. told investors the growth story was still intact. Consumption was stabilizing. $10 billion in product rev... Learn More

Navan, Inc. promised investors rapid growth. 33% percent revenue growth. 32% booking growth. A platform built for custom... Learn More

Lakeland Industries told investors its acquisition strategy was small, strategic, and quick. Pacific Helmets. Jolly Boot... Learn More

Zynex told investors it was changing pain management. Record orders. Record revenue. The Company touted profitability an... Learn More

Corcept told investors relacorilant was the future. A safer, next generation treatment for Cushing’s syndrome.   The... Learn More

NuScale told investors its small modular reactors were the future of clean energy. A game changer. A faster, safer path ... Learn More

Enphase told investors it could control its destiny. New products. Inventory discipline. Optimistic commentary about dem... Learn More

Ostin Technology told investors it was building a high growth display business. A Nasdaq listed company. New capital. Bi... Learn More

PayPal Holdings, Inc. told investors it was about to win checkout. Big growth. High single digits. Even double digit ear... Learn More

Regenxbio told investors it was on the brink of a breakthrough. A one time gene therapy. Encouraging biomarker data. No ... Learn More

uniQure told investors it was on the brink of something historic. A gene therapy that could actually slow Huntington’s... Learn More

Kyndryl told investors its financial controls were solid. Effective. Remediated. Nothing to worry about. But behind the ... Learn More

Inovio told investors it was on the verge of history. A breakthrough DNA medicine. Accelerated FDA approval. A fast trac... Learn More

Paysafe told investors it had strong banking relationships. Nearly 100 hundred banks. Solid growth. Clear guidance for 2... Learn More

BlackRock TCP sold itself as steady. Disciplined. A safe income play built on carefully valued loans. But behind the sce... Learn More

Ultragenyx Pharmaceutical Inc. promised a breakthrough. A rare disease drug. Strong data. And real hope for patients wit... Learn More

They promised hope. A breakthrough drug. And a future where fragile bones could finally get stronger. Mereo BioPharma to... Learn More

Here’s the story investors are now telling about Oracle Corporation. Oracle sold a powerful vision. AI everywhere. Dat... Learn More

Plug Power Inc. sold investors a bold dream. A nationwide network of clean hydrogen plants. Backed by a massive $1.66 bi... Learn More

Picard Medical told investors it was saving lives. A breakthrough artificial heart. A fresh Nasdaq debut. Big optimism. ... Learn More

Richtech Robotics told investors it had finally made it. A cutting-edge AI robot. A collaboration with Microsoft. Real v... Learn More

Ramaco told investors it was striking gold. A bold pivot into rare earth minerals. A brand-new mine. America’s first i... Learn More

Beyond Meat told investors the hard part was over. Costs were coming down. Margins were improving. And management promis... Learn More

BellRing Brands told investors it was finally hitting its stride. Organic growth. Strong demand. A powerful protein tail... Learn More

Vistagen told investors it was on the brink of a breakthrough. A first of its kind treatment for social anxiety. Phase T... Learn More

Bath and Body Works told investors it had cracked the code for growth. New categories. New customers. A fresh chapter be... Learn More

CoreWeave sold investors a dream. The AI hyperscaler. Massive demand. Billions in long-term contracts. In March 2025, ju... Learn More

Ardent Health sold investors a clean story. Strong collections. Disciplined accounting. A smooth IPO. But behind the opt... Learn More

Varonis told investors the future was bright. A smooth transition to SaaS. Stronger renewals. Growing recurring revenue... Learn More

Fermi sold investors a bold future. Massive nuclear power. AI data centers. And a flagship project called Project Matad... Learn More

Agilon Health sold investors a confident story. Strong guidance. Strategic actions. A stronger foundation for growth. ... Learn More

Klarna sold investors a feel-good story. Smart tech. Smarter credit. Responsible growth. But the truth hit hard. ... Learn More

SLM Corporation thought it had a steady story. High quality student loans. Strong credit. Delinquencies under control. ... Learn More

Coupang sold investors a story about trust, growth, and world class technology. A fast growing ecommerce giant. Strong ... Learn More

F5 told investors it was the gold standard in cybersecurity. Best in class. Unmatched protection. The company everyone ... Learn More

Integer Holdings told investors it was riding a powerful growth wave.  Electrophysiology devices. Pulse field ablati... Learn More

Blue Owl promised steady growth. Safe income. A rock-solid private credit machine.But behind all that confidence… s... Learn More

Bitdeer promised a future powered by its next-generation SEALMINER chips. Lightning-fast. Ultra-efficient. Ready for ma... Learn More

DeFi Technologies sold investors a story of “low‑risk” crypto arbitrage powering explosive, reliable growth. DeFi... Learn More

Alexandria told investors the life-science market was strong. Occupancy was solid. Leasing spreads were healthy. And it... Learn More

Sprouts Farmers Market spent 2025 telling investors a simple story. Their customers were loyal. Their sales were strong... Learn More

StubHub told investors the story everyone wanted to hear. A global marketplace. Huge demand. Strong cash flow. A fres... Learn More

Jayud Global promised investors a fast-growing logistics empire. A lean operation. Big global reach. A company on the... Learn More

Freeport-McMoran kept telling investors everything at its giant Indonesia copper mine was safe. Operations strong. Risk ... Learn More

Stride told families it was building one of the nation’s most successful online education platforms. Big vision. Big g... Learn More

They said the merger would change everything. A powerhouse. Coast-to-coast brands. Growth for years. That was the pitch.... Learn More

Firefly Aerospace just got hit with a major securities class-action lawsuit over its August 2025 IPO. Investors claim th... Learn More

Telix promised a future full of growth. New cancer drugs. A global rollout. A rock-solid supply chain. Investors were ex... Learn More

Molina Healthcare promised steady growth and solid earnings. Executives said medical costs were under control and 2025 w... Learn More

Marex promised strength. Solid liquidity, fast growth, and reliable profits. Investors believed it. But cracks started t... Learn More

CarMax promised investors smooth roads ahead. The CEO said the company was gaining market share, driving double-digit gr... Learn More

Synopsys told investors its AI-powered chip business was the future. Revenue was rising. Growth looked unstoppable. But ... Learn More

WPP told investors 2025 would be a year of balance and cautious growth. Executives said new business wins would ramp up,... Learn More

Avantor told investors it was holding strong against the competition. Executives said its lab business was “stacking u... Learn More

DexCom promised a life-saving G7 glucose monitor that was supposed to be the most accurate ever made. Investors believed... Learn More

James Hardie promised strength and stability — the “number one fiber cement brand in North America,” with booming ... Learn More

MoonLake promised a next generation breakthrough. Smaller nanobody. Better tissue reach. Higher responses. Easy monthly ... Learn More

Baxter sold a promise of safer care and a flagship pump that would power years of growth. Best in class. Seamless launch... Learn More

aTyr Pharma promised investors a breakthrough. Executives said their drug, efzofitimod, could let lung disease patients ... Learn More

Fortinet promised record growth. Executives said a massive firewall “refresh cycle” would drive hundreds of millions... Learn More

RCI Hospitality told investors it was running clean clubs and clean books. Turns out, that wasn’t true. From 2021 thro... Learn More

KBR told investors everything was going smoothly. The company said its HomeSafe program — a joint venture with the U.S... Learn More

Levi & Korsinsky recently prevailed in a securities fraud appeal at the Second Circuit of Appeals in the matter of ... Learn More

Savant v. iRobot Corporation, et al., Case No. 1:25-cv-05563 (S.D.N.Y.) is a securities fraud class action pending befor... Learn More

Replimune said everything was good to go with its FDA application for a cancer drug. The data looked great. The FDA was ... Learn More

RxSight boasted about booming demand for its cataract surgery system.  But, in the end, the company took the scalpel to... Learn More

Alto Neurosciences hyped up the promise of its new depression treatment.  But in the end, all that was left were broken... Learn More